None listed
Conditions
Brief summary
Mindfulness has been shown to be effective in treating fatigue and mood problems in people with MS. At the same time, there is evidence that training in mindfulness meditation can improve brain function - specifically increasing the volume of the hippocampus - in healthy people. MS is characterised by hippocampal loss early in the progression of the disease. This research project asks whether mindfulness could potentially protect against hippocampal loss in people with multiple sclerosis.
Interventions
Mindfulness Meditation training will be conducted in groups of approximately 10 patients per group. Participants will be contacted by the trained Mindfulness therapist (Alice Shires) and given information about the group that they have been allocated to. Each group session will be 2 hours and will be conducted on a weekly basis for 8 weeks. Mindfulness training is a form of attentional training which requires a daily practice of deliberately focusing attention on one’s own experience from moment to moment and in a non-judgmental way. Participants are helped to develop the ability to quickly recognise and inhibit their typical response to emerging thoughts, to prevent distractibility and refocus their attention on the breath. As participants develop these skills, they are then taught to scan their body systematically and develop an ability to feel both salient and more subtle sensations while purposefully inhibiting habitual, learned reactions. As participants have learned to do with their thoughts, participants develop an increasing ability to accept whatever arises in their body from moment to moment while remaining as non-reactive as possible. Participants will be taught mindful meditation techniques which are practised in the group session and then particpants are encouraged to continue daily practice between group sessions using guided meditation practice via CDs distributed in the group sessions.
Sponsors
Study design
Eligibility
Inclusion criteria
Participants will be patients with a confirmed diagnosis from a Consultant Neurologist of MS
Exclusion criteria
(1) an Expanded Disability Status Scale (EDSS) < 6; (2) current serious psychiatric condition (excluding depressive and anxiety disorders), such as schizophrenia, bipolar disorder or drug and alcohol abuse; (3) evidence of cognitive impairment that would compromise their ability to take part in the study, as assessed by the Mini-Mental State Examination; (4) current MS exacerbation; (5) inability to complete the required questionnaires.